ERGIC3 and liver cancer: In addition, the high expression of ERGIC3 was positively correlated with the infiltration of B cells, macrophage, myeloid dendritic cells, CD4+ T and other immune cells, suggesting that ERGIC3 may affect the prognosis of liver cancer patients by raising the abundance of infiltrating immune cells.